VYNE – vyne therapeutics inc. (US:NASDAQ)
Stock Stats
News
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference [Yahoo! Finance]
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update
VYNE Therapeutics to Participate in March Investor Conferences
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Harsch Mutya
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Stuart Iain
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Domzalski David
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Zeronda Tyler
Form 10-K VYNE Therapeutics Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.